<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">Liver metastasis</z:e> (LM) is the determining factor of poor prognosis in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>Peripheral lymphatico-venous communications have been discussed as a potential pathway of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cell dissemination for the development of LMs </plain></SENT>
<SENT sid="2" pm="."><plain>In the current study, we investigated the clinical impact of the lymphangiogenic activity in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e> and their corresponding LMs </plain></SENT>
<SENT sid="3" pm="."><plain>PATIENTS AND METHODS: In 47 patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>, the <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumors</z:e> and the corresponding LMs were investigated </plain></SENT>
<SENT sid="4" pm="."><plain>Lymphangiogenesis (LMVD), lymphovascular invasion (LVI), lymphatic vascular endothelial growth factor C expression (VEGF-C) were investigated RESULTS: A significant correlation was observed between LMVD and LVI in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e> (p=0.001) as well as in LMs (p=0.0001) </plain></SENT>
<SENT sid="5" pm="."><plain>LMVD in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> correlated significantly with that in LMVD-LMs (p=0.026) and LVI in LMs (p=0.036) </plain></SENT>
<SENT sid="6" pm="."><plain>Survival analysis reveilled a significant difference in disease free and overall survival between patients with and without VEGF-C expression in LMs (p=0.0019 and p=0.0101, respectively) </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSION: Our data provide evidence for an important role of lymphangiogenesis in <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> and provide further support for a possible role of a lymphatico-venous metastatic pathway </plain></SENT>
</text></document>